Palbociclib for HR-Positive, HER2-Positive Breast Cancer

N Engl J Med. 2026 Apr 30;394(17):1764. doi: 10.1056/NEJMc2602522.

Authors

Saisai Jing¹, Jiazhao Song²

Affiliations

¹ Cixi People's Hospital, Cixi, China.
² Universitätsklinikum Erlangen, Erlangen, Germany.

PMID: 42054691
DOI: 10.1056/NEJMc2602522

No abstract available

Publication types

Letter
Comment